• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov14
H.C. Wainwright Reiterates Buy Rating on Bolt Biotherapeutics
16:02
Nov13
Bolt Biotherapeutics released FY2025 9 Months Earnings on November 12, 2025 EST, with actual revenue of USD 5.195 M and EPS of USD -13.9453
04:00
Bolt Biotherapeutics released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 2.169 M (forecast USD 820.8 K), actual EPS USD -3.7219 (forecast USD -5.426)
04:00
Aug15
Bolt Biotherapeutics released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 1.804 M (forecast USD 819.75 K), actual EPS USD -4.4643 (forecast USD -6.45)
03:00
Bolt Biotherapeutics released FY2025 Semi-Annual Earnings on August 14 EST, with actual revenue of USD 3.026 M and EPS of USD -10.2232
03:00
Jun11
Squarepoint Ops LLC Acquires New Shares of Bolt Biotherapeutics
07:29

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 2.169 M, Net Income -7.144 M, EPS -3.7219

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.804 M, Net Income -8.561 M, EPS -4.4643

Jun9
Reverse Stock Split(EST)

1-for-20 Reverse Stock Split

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FJET
8.500
+136.77%
+4.910
AFJK
52.230
+100.81%
+26.220
DJTU
5.160
+83.63%
+2.350
ATHA
6.720
+62.52%
+2.585
SOC
8.250
+56.25%
+2.970
ZNB
1.020
+55.73%
+0.365
VIVK
0.0751
+47.25%
+0.024
SGD
0.2518
+42.26%
+0.075
DJT
14.860
+41.93%
+4.390
VSME
0.1035
+38.37%
+0.029
View More